Skip to main navigation

Back

Contact Revance
Login

Menu

Aesthetics
Back Aesthetics
Visit Site
Therapeutics
Back Therapeutics
Investors
Back Investors
LATEST NEWS
Our Latest

December 22, 2020

Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection All News
Company
Back Company
OUR LATEST
Our Latest

December 22, 2020

Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection Our Latest
News
Careers
Back Careers

facebook
instagram
twitter
linkedin

1222 Demonbreun St
Suite 2000
Nashville, TN 37203

+1 (510) 742-3400

Contact Revance
Login

© Copyright 2021

All Rights Reserved

Breadcrumb

Home
Investors
Press releases

Press Releases

Press Releases

Items Per Page

Year

December 4, 2018

Revance Announces China Market License Agreement with Fosun Pharma for RT002

December 4, 2018

Revance’s RT002 Demonstrates Unprecedented Efficacy and Duration In Largest-Ever Aesthetic Neuromodulator Clinical Program

November 20, 2018

Revance to Participate in Upcoming Investor Conferences

November 7, 2018

Revance to Participate in the Credit Suisse Healthcare Conference

November 1, 2018

Revance Releases Third Quarter 2018 Results

October 18, 2018

Revance Therapeutics to Release Third Quarter 2018 Financial Results on Thursday, November 1, 2018

October 11, 2018

Revance Therapeutics Appoints Tobin C. Schilke as Chief Financial Officer

September 24, 2018

Revance to Participate in the Cantor Fitzgerald 2018 Global Healthcare Conference

September 20, 2018

Revance Receives Great Place to Work Certification

August 2, 2018

Revance Releases Second Quarter 2018 Results

Pagination

First page
Previous page
…
Page 6
Page 7
Page 8
Page 9
Current page 10
Page 11
Page 12
Page 13
Page 14
…
Next page
Last page

Displaying 91 - 100 of 242

Investor Relations

Investor Relations
Press Releases
Events & Webcasts
- Presentations and Corporate Materials
- Video Library
Corporate Governance
Financials & Filings
Stock Information
Analyst Coverage
Investor FAQs
Contact Us

image description

Revance - Shareholder Tools

Print Page
Printed Materials
Email Alerts
Download Library
RSS News Feeds
Share
Search

Keep up with Revance

Subscribe

1222 Demonbreun St
Suite 2000
Nashville, TN 37203

+1 (510) 742-3400

facebook
instagram
twitter
linkedin

Aesthetics

Overview
RHA®
HintMD
Neuromodulator
Neuromodulator Uses
Clinical Highlights

Therapeutics

Overview
Cervical Dystonia
Upper Limb Spasticity
Plantar Fasciitis
Clinical Highlights

Investors

Investor Relations
Press Releases
Events & Webcasts
Corporate Governance
Financials & Filings
Stock Information
Analyst Coverage
Investor FAQ

Company

Overview
About Revance
Leadership Team
Board of Directors
Partnerships
Investigator Sponsored Trials
Medical Education Grants
Sustainability
Contact Revance

News

All News
In the News
Our Latest

Careers

Overview
Career Opportunities
Culture
Benefits & Perks

© Copyright 2021
All Rights Reserved
Terms of Use
Privacy Policy
Corporate Social Media Community Guidelines

Facebook
LinkedIn